Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
fda
life sciences
national blog main
raleigh-durham blog main
5
×
san francisco blog main
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
ipo
national
cancer
chronic kidney disease
crispr
food and drug administration
glaxosmithkline
medical device
medical devices
messenger rna
parkinson's disease
pulmonary arterial hypertension
What
therapeutics
5
×
bio
companies
drug
immunotherapy
ipo
life
million
momentum
new
roundup
science
therapy
week
agency
aimmune
allergy
allogene
approval
approved
awarded
biotechs
black
building
cancer
club
continue
continued
crispr
crop
deal
debut
developed
developer
diamond
diamond’s
disease
diversity
established
exceeded
Language
unset
Current search:
biotech
×
therapeutics
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed